Keryx Biopharmaceuticals Inc
KERX
KERX was delisted on the 12th of December, 2018.
102 hedge funds and large institutions have $390M invested in Keryx Biopharmaceuticals Inc in 2013 Q2 according to their latest regulatory filings, with 102 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
40% less call options, than puts
Call options by funds: $20.2M | Put options by funds: $33.5M
Top Buyers
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
101
Bank of Montreal
Toronto,
Ontario, Canada
| $2K | +$1.95K | +250 | New |
|
|
JG
102
Jefferies Group
New York
| $1K | +$938 | +120 | New |
|
KERX Hedge Fund Activity: Q2 2013 in Review
102 of the 3,065 institutional investors tracked by Wall St. Rank reported a position in Keryx Biopharmaceuticals Inc (KERX) for Q2 2013, worth a combined $390M.
Buyers outnumbered sellers: 102 funds opened new KERX positions and 0 closed out — a net gain of 102 holders — while 0 added to existing stakes and 0 trimmed.
- 102 institutional investors held Keryx Biopharmaceuticals Inc (KERX) as of Q2 2013, up from 0 in Q1 2013.
- Funds reported $390M of Keryx Biopharmaceuticals Inc stock for Q2 2013.
- 102 funds opened new Keryx Biopharmaceuticals Inc positions in Q2 2013 and 0 closed out, a net change of +102 holders.
Based on aggregated 13F filings for Q2 2013.